Abstract
Background:
Intravaginal washing, practiced by a significant proportion of women globally, is associated with acquisition of human immunodeficiency virus (HIV), sexually transmitted infections, and bacterial vaginosis (BV). A single prior study among women in the United States found that vaginal washing was associated with lower fecundability.
Objective:
To examine the association between vaginal washing and fecundability among Kenyan women.
Methods:
HIV-negative Kenyan women who were trying to conceive and reported no history of infertility care-seeking were followed prospectively for incident pregnancy for up to six months. At monthly visits, participants reported the first day of last menstrual period, sexual behavior, vaginal washing behavior, underwent pregnancy testing, and provided vaginal swabs for detection of BV by Gram stain (Nugent score ≥7). Discrete time proportional probabilities models were used to estimate fecundability ratios (FR) and 95% confidence intervals (CI) comparing menstrual cycles when women reported vaginal washing to menstrual cycles when no vaginal washing was reported.
Results:
Four hundred fifty-eight women contributed 1,376 menstrual cycles and 255 pregnancies. At enrollment, a third (35.2%, 161 of 458) of participants reported vaginal washing with the majority using water only (73.9%, 119 of 161). After adjustment for age, frequency of unprotected intercourse, and study site, vaginal washing in the prior four weeks was associated with a 29% lower fecundability (adjusted FR (aFR) 0.71, 95% CI 0.53, 0.94), which did not change after further adjustment for BV at the visit prior to each pregnancy test (aFR 0.71, 95% CI 0.54, 0.95).
Conclusions:
Periconceptual vaginal washing may reduce fecundability. Potential mechanisms include vaginal washing-associated changes in the vaginal microbiota, inflammation, disruption of cervical mucus, and effects on sperm function. Vaginal washing has no known health benefits and cessation may improve women’s likelihood of conceiving.
Keywords: vaginal washing, fecundability, time-to-pregnancy, conception
SOCIAL MEDIA QUOTE
Vaginal washing was associated with a lower per-menstrual cycle probability of pregnancy among Kenyan women planning pregnancies. Vaginal washing has no known health benefits, and cessation may improve women’s likelihood of conceiving.
BACKGROUND
Intravaginal washing practices include cleansing with water or products such as vinegar, soaps, or douching agents.1 Many women globally engage in vaginal washing to improve hygiene, prevent pregnancy, prevent or treat vaginal infections, or promote sexual pleasure.1–7 Vaginal washing is associated with increased risk of bacterial vaginosis (BV), sexually transmitted infections (STI), human immunodeficiency virus (HIV), and pelvic inflammatory disease (PID).8–10 Only one prior study has assessed the association between vaginal douching and fecundability, finding lower fecundability among those engaging in vaginal douching.11 Our objective was to prospectively assess the association between vaginal washing and fecundability in Kenyan women planning pregnancy.
METHODS
Cohort selection and study procedures
Women in the Microbiota and Preterm Birth study, which enrolled women in Nairobi and Mombasa, Kenya between April 18, 2017 and March 18, 2020, were eligible for this fecundability analysis.12 The parent study included HIV-seronegative women who were ≤45 years old, were non-contracepting (other than condoms for STI prevention), reported a menstrual period in the prior three months (or recently discontinued hormonal contraception), and were planning to become pregnant in the next six months. Women were excluded if they were not at risk for pregnancy including having a depot medroxyprogesterone acetate (DMPA) injection within three months, were at increased risk for preterm birth (ex: autoimmune diseases), used antibiotics in the last four weeks (common exclusion criterion for vaginal microbiota studies), or previously sought care for infertility. For this fecundability analysis, we excluded participants who did not contribute ≥1 menstrual cycles, those with history of PID treated in hospital, ectopic pregnancy, polycystic ovary syndrome, or endometriosis, and those trying to conceive for >3 menstrual cycles prior to enrollment (eFigure 1).13,14
At enrollment, participants completed an interview including socio-behavioral characteristics and medical history including first day of last menstrual period (LMP) and how long they had been non-contracepting and attempting pregnancy, and underwent a pelvic examination with vaginal swab collection.12 At monthly preconception visits, participants underwent urine pregnancy testing, self-collected vaginal swabs, and completed an interview reporting sexual and vaginal washing behavior and first day of LMP. Participants were asked “Do you use anything to clean inside your vagina?” (no/yes). If “yes”, they were asked “In the four weeks prior to today, which of the following did you use to clean inside of your vagina?” including water only, soap and water, antiseptic, detergent, and other (specify). Most participants were eligible for up to six monthly preconception visits; those discontinuing DMPA <6 months before enrollment were eligible for up to 9 months.15
Participants with genital symptoms were assessed and treated per Kenyan syndromic management guidelines.16 Enrollment vaginal samples were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis (Aptima Combo-2 CT/NG Detection System, Aptima Trichomonas vaginalis assay; Hologic Incorporated). Directed treatment was provided for STIs detected at enrollment. Vaginal samples from all visits were assessed for BV using Nugent criteria.17
Exposure
Two time-varying measures of vaginal washing were considered: 1) any vaginal washing in the last four weeks (no/yes), and 2) type of vaginal washing in the last four weeks (none, water only, soap and water). Two cycles were characterized by antiseptic use and were included with soap and water. Three cycles with an “other” type of vaginal washing were included with either water only or soap and water based on review of the substances specified.
Outcome
For each participant, number of menstrual cycles to first incident pregnancy was calculated using reported first days of LMPs and monthly urine pregnancy test results.13 In July 2018, a question was added to the monthly interview for report of additional first days of LMPs (“interim menstrual cycles”) for women who missed preconception visits (n=82 cycles reported). One-hundred thirty participants had visits prior to July 2018 and in these cases “interim menstrual cycles” were derived (n=41 cycles), as previously described.13 Participants were censored during follow-up for biomedical infertility treatment (n=3), not conceiving during follow-up (n=73), withdrawal or loss to follow-up (n=49), and at the onset of the COVID-19 pandemic (n=35).
Statistical Analysis
We used discrete time proportional probabilities models to generate fecundability ratios (FR) and 95% confidence intervals (95% CI) estimating the association between vaginal washing and fecundability.14,18 For participants with prior conception attempt time, we utilized delayed entry to enter participants into the analysis at their current menstrual cycle of trying to reduce left truncation bias. Based on existing literature, knowledge of the study population, and consideration of causal relationships, maternal age (years: <25, 25–29, 30–34, 35–39, 40–45), frequency of unprotected intercourse in the prior four weeks (none, 1–4, 5–8, ≥9), and study site were included a priori in multivariable models.1,19 In a second adjusted model, we included BV (Nugent score ≥7) at the visit prior, as women may have engaged in vaginal washing because of BV.13
Missing data:
For 123 derived or reported “interim menstrual cycles” (8.9% of cycles) and for rare data missingness for attended visits (0.03% of cycles), missing vaginal washing and unprotected intercourse data were imputed using data from the last visit carried forward.
Sensitivity analyses:
First, we excluded those with potential sub-fecundity (N. gonorrhoeae, C. trachomatis, T. vaginalis or PID at enrollment, any history of PID diagnosis or treatment for N. gonorrhoeae, C. trachomatis, T. vaginalis, or syphilis; self-report of fibroids or unknown uterine abnormality; DMPA use within six months of enrollment, HIV-seropositive partner). Second, we excluded derived and reported menstrual cycles. Third, we included women reporting ≤6 menstrual cycles of pre-enrollment conception attempt time.
Ethics Approval
The Kenyatta National Hospital-University of Nairobi and University of Washington ethics committees approved this study. Participants provided written informed consent.
RESULTS
The 458 participants were a median of 29 years old (IQR 25–34) and most reported no prior conception attempt time (80.1%, n=367) (Table 1). There were 255 pregnancies across 1,376 menstrual cycles. Twenty-six percent (359 of 1376) of cycles were exposed to vaginal washing (Table 2), with water accounting for 20.9% (287 of 1376) of cycles and soap and water 5.2% (42 of 1376) of cycles. After adjustment for age, frequency of unprotected intercourse, and study site, vaginal washing in the prior four weeks was associated with a 29% lower fecundability (adjusted FR (aFR) 0.71, 95% CI 0.53,0.94), which was similar after further adjustment for BV (aFR 0.71, 95% CI 0.54, 0.95) (Table 2). Compared to no vaginal washing, vaginal washing with water only was associated with a 17% lower fecundability (aFR 0.83, 95% CI 0.62, 1.10) and vaginal washing with soap and water was associated with a 78% lower fecundability (aFR 0.22, 95% CI 0.07, 0.71). Results were similar for sensitivity analyses excluding women with potential sub-fecundity, excluding derived and reported cycles, and including participants with up to 6 cycles of pre-enrollment conception attempt time (eTable 1).
Table 1.
Enrollment characteristics for 458 Kenyan women trying to conceive
| Characteristic | Total N=458 |
|---|---|
| Demographics | |
| Age | |
| <25 | 87 (19.0) |
| 25–29 | 147 (32.1) |
| 30–34 | 121 (26.4) |
| 35–39 | 84 (18.3) |
| 40–45 | 19 (4.2) |
| Education Level | |
| <8 years | 29 (6.3) |
| 8–11 years | 137 (29.9) |
| 12–15 years | 207 (45.2) |
| ≥16 years | 85 (18.6) |
| Monthly Household Income (KSh)a | |
| <2,500 | 13 (2.9) |
| 2,500–10,000 | 136 (29.9) |
| 10,000–30,000 | 197 (43.3) |
| 30,000–75,000 | 70 (15.4) |
| >75,000 | 39 (8.6) |
| Married or living with partner | 439 (95.9) |
| Partner’s HIV-serostatusb | |
| HIV-seronegative | 345 (75.7) |
| HIV-seropositive | 22 (4.8) |
| Unknown | 89 (19.5) |
| Reproductive History | |
| Most recent contraceptive methodc | |
| None | 102 (22.3) |
| Condoms | 24 (5.2) |
| OCP | 10 (2.2) |
| DMPA Injectable | 18 (3.9) |
| Copper IUD | 127 (27.7) |
| Implant | 175 (38.2) |
| Other | 2 (0.4) |
| Ever pregnant | 430 (93.9) |
| Number of menstrual cycles of prior conception attempt timed | |
| 0 | 367 (80.1) |
| 1 | 59 (13.0) |
| 2 | 19 (4.2) |
| 3 | 13 (2.8) |
| Abnormal uterus (fibroids or other/unknown pathology)e | 8 (1.3) |
| Sexual behavior and vaginal washing in last 4 weeks | |
| Any vaginal washing | 161 (35.2) |
| Type of vaginal washing | |
| None | 297 (64.9) |
| Water only | 119 (26.0) |
| Soap + Water | 42 (9.2) |
| Antiseptics | 0 (0.0) |
| Frequency of unprotected intercoursef | |
| No unprotected intercourse | 43 (9.4) |
| 1–4 | 152 (33.3) |
| 5–8 | 115 (25.2) |
| ≥9 | 147 (32.2) |
| STIg and BV | |
| History of PID with outpatient treatment | 1 (0.2) |
| History of STIh | 6 (1.3) |
| N. gonorrhoeae | 3 (0.7) |
| C. trachomatis | 34 (7.5) |
| T. vaginalis | 4 (0.9) |
| BV (Nugent ≥7) | 164 (35.8) |
Abbreviations: BV–bacterial vaginosis, DMPA–depo medroxyprogesterone acetate, IUD–intrauterine device, KSh–Kenyan shillings, OCP–oral contraceptive pills, PID–pelvic inflammatory disease, STI–sexually transmitted infection
N=455
N=456
Participants reporting OCP, contraceptive implant, or copper IUD discontinuation >2 months prior to enrollment or a last DMPA injection >6 months prior to enrollment were classified as ‘none’ for this analysis.
Women reporting >3 cycles of conception attempt time prior to enrollment were excluded for this analysis.
Self-reported
N=457
STI results were missing for N=4 for N. gonorrhoeae, N=4 for C. trachomatis, and N=5 for T. vaginalis
Self-reported history of syphilis, chlamydia, gonorrhea, and/or trichomoniasis
Table 2.
Unadjusted and adjusted association between vaginal washing and fecundability among 458 Kenyan women trying to conceive
| Exposure | Menstrual Cycles Exposed (N=1376) |
Pregnancies Exposed (N=255) |
Unadjusted FR | Model 1: Adjusted FRa |
Model 2: Adjusted FRb |
|---|---|---|---|---|---|
| n(%) | n(%) | (95% CI) | (95% CI) | (95% CI) | |
| Primary Analysis | |||||
| Any vaginal washing in last 4 weeks | |||||
| No | 1017 (73.9) | 204 (80.0) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Yes | 359 (26.1) | 51 (20.0) | 0.72 (0.54, 0.96) | 0.71 (0.53, 0.94) | 0.71 (0.54, 0.95) |
| Secondary Analysis | |||||
| Type of vaginal washing in last 4 weeks | |||||
| None | 1017 (73.9) | 204 (80.0) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Water only | 287 (20.9) | 48 (18.8) | 0.85 (0.63, 1.13) | 0.83 (0.62, 1.10) | 0.83 (0.62, 1.11) |
| Soap and waterc | 72 (5.2) | 3(1.2) | 0.21 (0.07, 0.67) | 0.22 (0.07, 0.71) | 0.23 (0.07, 0.71) |
Maternal age, study site, and frequency of unprotected intercourse were included in Model #1.
Maternal age, study site, frequency of unprotected intercourse, and BV at the visit prior (time-varying) were included in Model #2.
Includes n=2 cycles with report of antiseptic use.
COMMENT
Principal Findings
Among Kenyan women, recent vaginal washing was associated with a 29% lower per-menstrual cycle probability of pregnancy. Compared to those reporting no vaginal washing, vaginal washing with soap and water was associated with a 78% lower fecundability.
Strengths of the study
Strengths include the prospective design, monthly ascertainment of vaginal washing, and inclusion of the first menstrual cycle at-risk for pregnancy for most participants.
Limitations of the data
First, data on frequency, timing in relation to intercourse, and reasons for vaginal washing were not collected, so we were unable to assess these characteristics. Second, sexual frequency was not collected for a biologically-confirmed fertile window, which may contribute to residual confounding. Lastly, we were unable to assess mediation of the association between vaginal washing and fecundability by the vaginal microbiota.
Interpretation
Our results are similar to the only other study of vaginal washing and fecundability we are aware of.11 In a retrospective cohort study of vaginal douching among 840 women in King County, WA, vaginal douching >2 times/year prior to pregnancy was associated with a 31% lower fecundability compared to never/rare vaginal douching.
Vaginal washing may reduce the presence or concentration of optimal Lactobacillus species and promote ascension of BV-associated bacteria to the upper reproductive tract causing sub-clinical or clinical PID.7,8,20–22 There could also be an inflammatory response to vaginal washing independent of microbiota, as well as effects on cervical mucus.
Whether associations between vaginal washing and adverse reproductive outcomes are causal versus due to a BV episode that precipitated the vaginal washing is debated.9,23,24 We previously reported associations between recent and persistent BV and lower fecundability in this cohort.13 Our current analysis assessing vaginal washing had similar results in adjusted models with or without BV. Due to the timing of sample collection visits and monthly assessment of vaginal washing behavior, we are unable to employ marginal structural models to assess mediation of the association between vaginal washing and lower fecundability by BV. A study addressing this question would need to measure both vaginal washing and BV at more than one point during each menstrual cycle.
CONCLUSIONS
Among Kenyan women attempting pregnancy, there was an association between recent vaginal washing and lower fecundability that was strongest among those using soap and water. Vaginal washing cessation may improve women’s likelihood of conceiving.
Supplementary Material
SYNOPSIS.
Study question:
Is vaginal washing associated with fecundability among Kenyan women trying to conceive?
What’s already known:
Intravaginal washing, practiced by a significant proportion of women globally, is associated with acquisition of HIV, sexually transmitted infections, and bacterial vaginosis.
What this study adds:
Any vaginal washing in the four weeks before pregnancy testing was associated with a 29% lower per-menstrual cycle probability of pregnancy. Compared to those reporting no vaginal washing, vaginal washing with soap and water was associated with a 78% lower fecundability. Vaginal washing has no known health benefits and cessation may improve women’s likelihood of conceiving.
Acknowledgements:
We thank the study staff in Nairobi, Mombasa, and Seattle for their commitment, creativity, and teamwork. We are also grateful to Kenyatta National Hospital, Coast General Teaching and Referral Hospital, and the Mombasa County Department of Health for supporting this research and providing clinical and laboratory space. Lastly, we are deeply appreciative of the participants’ dedication to this study.
Funding:
This work was supported by a National Institutes of Health grant (NICHD R01 HD087346-RSM). RSM received additional support for mentoring (NICHD K24 HD88229). EML was supported by a post-doctoral fellowship (NICHD F32 HD100202). Data were collected using a REDCap electronic data capture tool hosted at the University of Washington’s Institute of Translational Health Science supported by grants from NCATS/NIH (UL1 TR002319). The content of this paper is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.
Conflict of Interest Statement:
RSM receives research funding, paid to the University of Washington, from Hologic Incorporated.
Footnotes
Presentation Information: This research was presented as an oral presentation at the STI & HIV 2021 World Congress held virtually on July 14–17, 2021.
REFERENCES
- 1.Nsereko E, Moreland PJ, Dunlop AL, Nzayirambaho M, Corwin EJ. Consideration of cultural practices when characterizing the vaginal microbiota among African and African American women. Biological Research for Nursing 2021;23:91–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Masese L, McClelland RS, Gitau R, Wanje G, Shafi J, Kashonga F, et al. A pilot study of the feasibility of a vaginal washing cessation intervention among Kenyan female sex workers. Sexually Transmitted Infections 2013;89:217–222. [DOI] [PubMed] [Google Scholar]
- 3.Hull T, Hilber AM, Chersich MF, Bagnol B, Prohmmo A, Smit JA, et al. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: Findings from a multicountry household survey. Journal of Women’s Health 2011;20:1097–1109. [DOI] [PubMed] [Google Scholar]
- 4.Kinuthia J, Richardson BA, Drake AL, Matemo D, Unger JA, Mcclelland RS, et al. Sexual behavior and vaginal practices during pregnancy and postpartum: Implications for HIV prevention strategies. Journal of Acquired Immune Deficiency Syndromes 2017;74:142–149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Crann SE, Cunningham S, Albert A, Money DM, O’Doherty KC. Vaginal health and hygiene practices and product use in Canada: A national cross-sectional survey. BMC Women’s Health 2018;18:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.United States National Center for Health Statistics. Key Statistics from the National Survey of Family Growth - D Listing: Douching, vaginal. https://www.cdc.gov/nchs/nsfg/key_statistics/d.htm#douching (last accessed June 2021).
- 7.Lokken EM, Manguro GO, Abdallah A, Ngacha C, Shafi J, Kiarie J, et al. Association between vaginal washing and detection of Lactobacillus by culture and quantitative PCR in HIV-seronegative Kenyan women: A cross-sectional analysis. Sexually Transmitted Infections 2019;95:455–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, McGregor J, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstetrics & Gynecology 2002;100:765–772. [DOI] [PubMed] [Google Scholar]
- 9.Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JHHM, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: Individual participant data meta-analysis. PLoS Medicine 2011;8:e1000416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Scholes D, Daling J, Stergachis A, Weiss N, Wang S, Grayston J. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstetrics & Gynecology 1993:601–606. [PubMed] [Google Scholar]
- 11.Baird DD, Weinberg CR, Voigt LF, Daling JR. Vaginal douching and reduced fertility. American Journal of Public Health 1996;86:844–850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lokken EM, Mandaliya K, Srinivasan S, Richardson BA, Kinuthia J, Lannon S, et al. Impact of preconception vaginal microbiota on women’s risk of spontaneous preterm birth: protocol for cohort study a prospective case-cohort study. BMJ Open 2020;10:e035186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lokken EM, Manhart LE, Kinuthia J, Hughes JP, Jisuvei C, Mwinyikai K, et al. Association between bacterial vaginosis and fecundability in Kenyan women planning pregnancies: a prospective preconception cohort study. Human Reproduction 2021;36:1279–1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Weinberg CR, Baird DD, Wilcox AJ. Sources of bias in studies of time to pregnancy. Statistics in Medicine 1994;13:671–681. [DOI] [PubMed] [Google Scholar]
- 15.Yland JJ, Bresnick KA, Hatch EE, Wesselink AK, Mikkelsen EM, Rothman KJ, et al. Pregravid contraceptive use and fecundability: prospective -cohort study. Human Reproduction 2020;371:m3966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.National AIDS & STI Control Programme of Kenya. Kenya National Guidelines for Prevention, Management and Control of Sexually Transmitted Infections. Nairobi, Kenya; 2018. [Google Scholar]
- 17.Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. Journal of Clinical Microbiology 1991;29:297–301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Weinberg C, Wilcox A, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. American Journal of Epidemiology 1989;129:1072–1078. [DOI] [PubMed] [Google Scholar]
- 19.Wesselink AK, Rothman KJ, Hatch EE, Mikkelsen EM, Sorensen HT, Wise LA. Age and fecundability in a North American preconception cohort study. American Journal of Obstetrics and Gynecology 2017;217:667.e1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Beigi RH, Wiesenfeld HC, Hillier SL, Straw T, Krohn MA. Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. Journal of Infectious Diseases 2005;191:924–929. [DOI] [PubMed] [Google Scholar]
- 21.Haggerty CL, Totten PA, Tang G, Astete SG, Ferris MJ, Norori J, et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sexually Transmitted Infections 2016;92:441–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Taylor BD, Darville T, Haggerty CL. Does bacterial vaginosis cause pelvic inflammatory disease? Sexually Transmitted Diseases 2013;40:117–122. [DOI] [PubMed] [Google Scholar]
- 23.Brotman RM, Klebanoff MA, Nansel TR, Andrews WW, Schwebke JR, Zhang J, et al. A longitudinal study of vaginal douching and bacterial vaginosis - A marginal structural modeling analysis. American Journal of Epidemiology 2008;168:188–196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gondwe T, Ness R, Totten PA, Astete S, Tang G, Gold MA, et al. Novel bacterial vaginosis-associated organisms mediate the relationship between vaginal douching and pelvic inflammatory disease. Sexually Transmitted Infections 2020;96:439–444. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
